| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74b7b50944d8e1960440fb1f5440b7fd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
1995-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c23fc2ddb771a5438c278e7757d54680
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_210b2da60665e2839f747104354cac1e |
| publicationDate |
1995-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9535120-A1 |
| titleOfInvention |
Monoclonal antibodies for the reduction of anti-xenogeneic immune responses |
| abstract |
Monoclonal antibodies are provided that react with pig antigen presenting cells (APCs), inhibit a human/porcine xenogeneic mixed lymphocyte response (MLR), do not react with human APCs, and do not react with pig major histocompatibility (MHC) molecules. The monoclonal antibodies can be used to reduce the rejection of pig xenografts by the human immune system. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6197294-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6506891-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2583678-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7189837-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9420770-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6225448-B1 |
| priorityDate |
1994-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |